MyFinsight
Home
About
Contact
apre: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, APRE has $14,321,316 in assets.
Balance Sheets Overview
Assets Breakdown
Other noncurrent assets
0
Subscribe for Financial Insights
Page 1
Unit: Dollar
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Other noncurrent assets
271,162
271,162
Total assets
14,321,316
17,309,710
Total liabilities and stockholders' equity
14,321,316
17,309,710
Unit: Dollar
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$225,936
Cash and cash
equivalents
$13,718,052
Other noncurrent
assets
$271,162
Restricted cash
$40,930
Property and equipment,
net
$65,236
Total current assets
$13,943,988
Total assets
$14,321,316
Total liabilities and
stockholders' equity
$14,321,316
Total stockholders'
equity
$10,912,848
Series a convertible
preferred stock, 0.001 par...
$727,361
Total current
liabilities
$2,681,107
Accumulated deficit
-$331,185,811
Accumulated other
comprehensive loss
-$10,629,534
Additional paid-in capital
$352,722,214
Accrued expenses
$2,039,785
Accounts payable
$641,322
Common stock, 0.001 par
value, 400,000,000...
$5,979
Subscribe for Financial Insights
Aprea Therapeutics, Inc. (APRE)
Aprea Therapeutics, Inc. (APRE)